NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
171 hedge funds and large institutions have $1.68B invested in NxStage Medical Inc. in 2017 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 60 reducing their positions, and 26 closing their positions.
391% more call options, than puts
Call options by funds: $1.11M | Put options by funds: $226K
31% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 26
4% more capital invested
Capital invested by funds: $1.61B → $1.68B (+$67.7M)
1% more funds holding
Funds holding: 170 → 171 (+1)
13% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 60
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$122M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$56.2M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$15.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$14.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$13.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$21.9M |
| 2 |
Jennison Associates
New York
|
-$18.7M |
| 3 |
DM
Deerfield Management
New York
|
-$14.2M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$10.7M |
| 5 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$9.81M |
NXTM Hedge Fund Activity: Q1 2017 in Review
171 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2017, worth a combined $1.68B — up 4.2% from $1.61B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new NXTM positions and 26 closed out — a net gain of 8 holders — while 52 added to existing stakes and 60 trimmed.
The largest buyer was BlackRock, adding an estimated $122M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $21.9M.
- 171 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2017, up from 170 in Q4 2016.
- Funds reported $1.68B of NxStage Medical Inc. stock for Q1 2017, up 4.2% quarter-over-quarter.
- 34 funds opened new NxStage Medical Inc. positions in Q1 2017 and 26 closed out, a net change of +8 holders.
- The largest NxStage Medical Inc. buyer in Q1 2017 was BlackRock, an estimated $122M added.
- The largest NxStage Medical Inc. seller in Q1 2017 was Gilder Gagnon Howe & Co, an estimated $21.9M sold.
Based on aggregated 13F filings for Q1 2017.